Lehrstuhl für Innere Medizin IV

Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction (2021) Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, et al. Journal article Novel approaches to management of hypertension (2021) Bosch A, Schmieder R Journal article, Review article Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension (2021) Schmieder R, Kandzari DE, Wang TD, Lee YH, Lazarus G, Pathak A Journal article 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation (2020) Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp AS, Schmieder R, Wang Y, et al. Journal article Tissue sodium content in hypertension and related organ damage (2020) Kolwelter J, Uder M, Schmieder R Journal article, Review article Influence of officially ordered restrictions during the first wave of COVID-19 pandemic on physical activity and quality of life in patients after kidney transplantation in a telemedicine based aftercare program—a KTx360° sub study (2020) Hanke AA, Sundermeier T, Boeck HT, Schieffer E, Boyen J, Braun AC, Rolff S, et al. Journal article Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography (2020) Jung S, Bosch A, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder R Journal article Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis (2020) Predel HG, Weisser B, Wassmann S, Schmieder R, Blettenberg J, Gillessen A, Fournier , et al. Conference contribution Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis (2020) Predel HG, Weisser B, Schmieder R, Wassmann S, Blettenberg J, Gillessen A, Fournier , et al. Conference contribution Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes (2020) Jung S, Bosch A, Kannenkeril D, Karg MV, Striepe K, Bramlage P, Ott C, et al. Journal article